Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 14-Nov-24 5:21 PM View:  | Almenoff June Sherie Director | Avalo Therapeutics, Inc. (CERC) | 13-Nov-24 | Purchase | 500 | $13.00 | $6,500.00 | 100% 0.5K to 1.0K | |
| 14-Nov-24 5:21 PM View: | Almenoff June Sherie Director | Avalo Therapeutics, Inc. (CERC) | 12-Nov-24 | Purchase | 500 | $12.50 | $6,249.50 | 100% 0 to 0.5K | |
| 28-Jun-23 6:12 PM View: | Armistice Capital, LLC 10% Owner | Avalo Therapeutics, Inc. (CERC) | 27-Jun-23 | Sale | 937,404 | $0.52 | $486,888.00 | (55%) 1.7M to 765.83K | |
| 28-Jun-23 6:12 PM View: | Armistice Capital, LLC 10% Owner | Avalo Therapeutics, Inc. (CERC) | 26-Jun-23 | Sale | 2,746,140 | $0.61 | $1,682,010.00 | (62%) 4.45M to 1.7M | |
| 27-Jun-23 4:10 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 26-Jun-23 | Purchase | 1,425,700 | $0.64 | $917,153.00 | (89%) 1.61M to 182.3K | |
| 27-Jun-23 4:10 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 26-Jun-23 | Purchase | 182,300 | $0.62 | $113,026.00 | (100%) 182.3K to 0 | |
| 20-Jun-23 4:04 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 20-Jun-23 | Purchase | 2,000 | $4.14 | $8,288.80 | < 1% 1.61M to 1.61M | |
| 20-Jun-23 4:04 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 16-Jun-23 | Purchase | 3,000 | $3.90 | $11,714.40 | < 1% 1.6M to 1.61M | |
| 20-Jun-23 4:04 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 15-Jun-23 | Purchase | 3,160 | $3.68 | $11,640.50 | < 1% 1.6M to 1.6M | |
| 14-Jun-23 4:14 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 14-Jun-23 | Purchase | 6,000 | $3.48 | $20,874.00 | < 1% 1.59M to 1.6M | |
| 14-Jun-23 4:14 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 13-Jun-23 | Purchase | 8,750 | $3.82 | $33,439.00 | < 1% 1.59M to 1.59M | |
| 14-Jun-23 4:14 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 12-Jun-23 | Purchase | 2,149 | $4.34 | $9,316.34 | < 1% 1.58M to 1.59M | |
| 09-Jun-23 4:24 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 09-Jun-23 | Purchase | 5,044 | $4.14 | $20,895.80 | < 1% 1.58M to 1.58M | |
| 13-Jun-23 4:39 PM View: | Neil Garry Arthur CEO and Chairman of the Board Director | Avalo Therapeutics, Inc. (CERC) | 09-Jun-23 | Purchase | 4,000 | $3.42 | $13,680.00 | 43% 9.22K to 13.22K | |
| 13-Jun-23 4:41 PM View: | Sullivan Christopher Ryan Chief Financial Officer | Avalo Therapeutics, Inc. (CERC) | 09-Jun-23 | Purchase | 511 | $3.42 | $1,747.62 | 68% 0.75K to 1.26K | |
| 09-Jun-23 4:24 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 08-Jun-23 | Purchase | 6,398 | $3.93 | $25,125.60 | < 1% 1.57M to 1.58M | |
| 09-Jun-23 4:24 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 07-Jun-23 | Purchase | 2,984 | $3.49 | $10,418.30 | < 1% 1.57M to 1.57M | |
| 02-Jun-23 4:22 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 31-May-23 | Market Purchase | 844 | $2.87 | $2,422.28 | < 1% 1.57M to 1.57M | 2% |
| 30-May-23 4:27 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 30-May-23 | Market Purchase | 671 | $2.87 | $1,923.76 | < 1% 1.57M to 1.57M | 2% |
| 30-May-23 4:27 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 25-May-23 | Market Purchase | 2,000 | $2.77 | $5,540.00 | < 1% 1.56M to 1.57M | 6% |
| 24-May-23 4:15 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 24-May-23 | Market Purchase | 9,000 | $2.98 | $26,816.40 | < 1% 1.56M to 1.56M | (2%) |
| 22-May-23 4:30 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 22-May-23 | Purchase | 7,000 | $3.34 | $23,357.60 | < 1% 1.55M to 1.56M | |
| 22-May-23 4:30 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 19-May-23 | Purchase | 6,500 | $3.52 | $22,852.10 | < 1% 1.54M to 1.55M | |
| 22-May-23 4:30 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 18-May-23 | Purchase | 13,121 | $3.29 | $43,162.80 | < 1% 1.53M to 1.54M | |
| 16-May-23 5:23 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 16-May-23 | Purchase | 379 | $2.75 | $1,042.25 | < 1% 1.53M to 1.53M | |
| 16-May-23 5:23 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 15-May-23 | Purchase | 1,715 | $2.55 | $4,366.22 | < 1% 1.53M to 1.53M | |
| 16-May-23 5:23 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 12-May-23 | Private Purchase | 2,285 | $2.45 | $5,598.25 | < 1% 1.52M to 1.53M | |
| 08-May-23 4:10 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 08-May-23 | Private Purchase | 5,000 | $2.62 | $13,108.00 | < 1% 1.52M to 1.52M | |
| 08-May-23 4:10 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 05-May-23 | Market Purchase | 5,000 | $2.88 | $14,375.00 | < 1% 1.51M to 1.52M | 2% |
| 08-May-23 4:10 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 04-May-23 | Market Purchase | 15,000 | $2.79 | $41,881.50 | < 1% 1.5M to 1.51M | 5% |
| 27-Apr-23 4:07 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 27-Apr-23 | Market Purchase | 1,504 | $2.96 | $4,451.84 | < 1% 1.5M to 1.5M | (1%) |
| 27-Apr-23 4:07 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 26-Apr-23 | Market Purchase | 425 | $2.97 | $1,262.25 | < 1% 1.5M to 1.5M | (1%) |
| 27-Apr-23 4:07 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 25-Apr-23 | Market Purchase | 5,571 | $3.00 | $16,709.10 | < 1% 1.49M to 1.5M | (2%) |
| 24-Apr-23 4:32 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 24-Apr-23 | Market Purchase | 12,500 | $3.06 | $38,280.00 | < 1% 1.48M to 1.49M | (4%) |
| 24-Apr-23 4:32 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 20-Apr-23 | Market Purchase | 5,000 | $3.08 | $15,391.50 | < 1% 1.48M to 1.48M | (5%) |
| 18-Apr-23 4:08 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 18-Apr-23 | Market Purchase | 10,000 | $2.94 | $29,438.00 | < 1% 1.47M to 1.48M | (< 1%) |
| 18-Apr-23 4:08 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 17-Apr-23 | Market Purchase | 15,000 | $2.96 | $44,436.00 | 1% 1.45M to 1.47M | (1%) |
| 11-Apr-23 4:51 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 11-Apr-23 | Purchase | 25,000 | $2.84 | $71,080.00 | 2% 1.43M to 1.45M | |
| 11-Apr-23 4:51 PM View: | Caissa Capital Management L... 10% Owner | Avalo Therapeutics, Inc. (CERC) | 10-Apr-23 | Private Purchase | 31,329 | $2.28 | $71,436.40 | 2% 1.39M to 1.43M | |
| 09-Feb-23 4:32 PM View: | Armistice Capital, LLC 10% Owner | Avalo Therapeutics, Inc. (CERC) | 07-Feb-23 | Purchase | 450,000 | -- | -- | 11% 4.0M to 4.45M | |
| 09-Feb-23 4:32 PM View: | Armistice Capital, LLC 10% Owner | Avalo Therapeutics, Inc. (CERC) | 03-Feb-23 | Acquisition (small) | 334 | $3.95 | $1,319.30 | < 1% 4.0M to 4.0M | |
| 12-Dec-22 4:22 PM View: | Neil Garry Arthur CEO and Chairman of the Board Director | Avalo Therapeutics, Inc. (CERC) | 09-Dec-22 | Purchase | 2,083 | $4.42 | $9,206.86 | 29% 7.14K to 9.22K | |
| 14-Mar-22 5:38 PM View: | Armistice Capital, LLC Director 10% Owner | Avalo Therapeutics, Inc. (CERC) | 14-Mar-22 | Purchase | 100,000 | $0.65 | $64,940.00 | < 1% 47.89M to 47.99M | |
| 14-Mar-22 5:38 PM View: | Armistice Capital, LLC Director 10% Owner | Avalo Therapeutics, Inc. (CERC) | 11-Mar-22 | Purchase | 100,000 | $0.69 | $68,780.00 | < 1% 47.79M to 47.89M | |
| 14-Mar-22 5:38 PM View: | Armistice Capital, LLC Director 10% Owner | Avalo Therapeutics, Inc. (CERC) | 10-Mar-22 | Private Purchase | 26,000 | $0.70 | $18,226.00 | < 1% 47.76M to 47.79M | |
| 07-Mar-22 6:09 PM View: | Armistice Capital, LLC Director 10% Owner | Avalo Therapeutics, Inc. (CERC) | 07-Mar-22 | Purchase | 325,000 | $0.66 | $213,330.00 | < 1% 47.44M to 47.76M | |
| 07-Mar-22 6:09 PM View: | Armistice Capital, LLC Director 10% Owner | Avalo Therapeutics, Inc. (CERC) | 04-Mar-22 | Purchase | 135,000 | $0.70 | $95,107.50 | < 1% 47.3M to 47.44M | |
| 07-Mar-22 6:09 PM View: | Armistice Capital, LLC Director 10% Owner | Avalo Therapeutics, Inc. (CERC) | 03-Mar-22 | Private Purchase | 50,000 | $0.71 | $35,695.00 | < 1% 47.25M to 47.3M | |
| 28-Feb-22 5:53 PM View: | Armistice Capital, LLC Director 10% Owner | Avalo Therapeutics, Inc. (CERC) | 25-Feb-22 | Purchase | 40,000 | $0.79 | $31,716.00 | < 1% 47.21M to 47.25M | |
| 28-Feb-22 5:53 PM View: | Armistice Capital, LLC Director 10% Owner | Avalo Therapeutics, Inc. (CERC) | 24-Feb-22 | Private Purchase | 100,000 | $0.80 | $80,090.00 | < 1% 47.11M to 47.21M |
